Titolo	Data di pubblicazione	Autore(i)
1	Vitamin D pathway polymorphisms impact on HBV interferon treatment outcomes in a cohort of HBeAg negative patients	2015	Cusato, Jessica; Boglione, Lucio; De Nicolo’, Amedeo; Cardellino, Chiara Simona; Imbornone, Rosaria; Cariti, Giuseppe; Di Perri, Giovanni; D’Avolio, Antonio
2	Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients	2018	Cusato, Jessica; De Nicolò, Amedeo; Boglione, Lucio; Favata, Fabio; Ariaudo, Alessandra; Mornese Pinna, Simone; Carcieri, Chiara; Guido, Federica; Avataneo, Valeria; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
3	Vitamin D pathway gene variants and HCV-2/3 therapy outcomes.	2015	Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Baietto, Lorena; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio
4	Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia	2016	Cusato, Jessica; Boglione, Lucio; DE NICOLO', Amedeo; Cardellino, Chiara Simona; Carcieri, Chiara; Cariti, Giuseppe; DI PERRI, Giovanni; D'Avolio, Antonio
5	Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs	2018	Cusato, Jessica; Boglione, Lucio; De Nicolò, Amedeo; Favata, Fabio; Ariaudo, Alessandra; Mornese Pinna, Simone; Guido, Federica; Avataneo, Valeria; Cantù, Marco; Carcieri, Chiara; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
6	Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy	2018	Cusato, Jessica; Nicolò, Amedeo De; Boglione, Lucio; Favata, Fabio; Ariaudo, Alessandra; Pinna, Simone Mornese; Carcieri, Chiara; Guido, Federica; Cariti, Giuseppe; Perri, Giovanni Di; D'Avolio, Antonio
7	Visceral leishmaniasis in a patient with active HBV/HDV co-infection	2019	Lupia T.; Corcione S.; Boglione L.; Cariti G.; De Rosa F.G.
8	Virological response and safety in a cohort of immigrant patients affected by chronic hepatitis delta treated with PEG-IFN	2018	Boglione, L.; Cariti, G.; Lupia, T.; Pinna, S.M.; Ghisetti, V.; DI Perri, G.
9	VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia.	2015	Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio
10	VDR gene polymorphisms impact on anemia at 2 week of anti-HCV therapy: a possible mechanism for early RBV-induced anemia.	2015	Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; De Nicolò, Amedeo; Cariti, Giuseppe; Di Perri, Giovanni; D’Avolio, Antonio
11	UPLC-MS/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells	2015	DE NICOLO', Amedeo; Abdi, Adnan Mohamed; Boglione, Lucio; Baietto, Lorena; Allegra, Sarah; DI PERRI, Giovanni; D'Avolio, Antonio
12	UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients	2015	DE NICOLO', Amedeo; Simiele, Marco; Pensi, Debora; Boglione, Lucio; Allegra, Sarah; DI PERRI, Giovanni; D'Avolio, Antonio
13	A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir.	2013	D'Avolio A;De Nicolò A;Agnesod D;Simiele M;Mohamed Abdi A;Dilly Penchala S;Boglione L;Cariti G;Di Perri G
14	UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients	2016	DE NICOLO', Amedeo; Bonifacio, Gabriele; Boglione, Lucio; Cusato, Jessica; Pensi, Debora; Tomasello, Cristina; DI PERRI, Giovanni; D'Avolio, Antonio
15	A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma	2016	Ariaudo, Alessandra; Favata, Fabio; De Nicolò, Amedeo; Simiele, Marco; Paglietti, Luca; Boglione, Lucio; Cardellino, Chiara Simona; Carcieri, Chiara; Di Perri, Giovanni; D'Avolio, Antonio
16	A UHPLC-MS/MS method for the quantification of currently used direct antiviral agents in human plasma and evaluation of "normalized matrix effect"	2016	D'Avolio, A.; Ariaudo, A.; Favata, F.; De Nicolò, A.; Simiele, M.; Boglione, L.; Carcieri, C.; Di Perri, G.
17	Triple or dual therapy for HCV-1 naive patients? Optimizing selection tools.	2014	Boglione L;De Nicolò A;Di Perri G;D'Avolio A
18	Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study	2017	Boglione, Lucio; Cardellino, Chiara Simona; Cusato, Jessica; De Nicolò, Amedeo; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
19	Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: a prospective study	2017	Boglione, Lucio; Mornese Pinna, Simone; De Nicolò, Amedeo; Cusato, Jessica; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
20	Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors	2017	Boglione, Lucio; Pinna, Simone Mornese; Cardellino, Chiara Simona; De Nicolò, Amedeo; Cusato, Jessica; Carcieri, Chiara; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio